Pod Save America Hosts Call on Democrats to Cut All Israel Military Aid, No Longer Accept AIPAC Funding
Jews, Israelis Targeted in Austria Amid Surge in Antisemitic Incidents; Local Jewish Community Calls for Action
‘All of Our Strength’: Over 1,000 Pro-Israel Activists Gather in DC for Solidarity Conference
‘Devastated’: Wesley LePatner, Killed in Manhattan Mass Shooting, Was a Jewish Communal, Philanthropic Leader
Sen. Angus King Vows to No Longer Vote for Israel Military Aid Until Gaza Conditions Improve
Europe Won’t Pressure Israel to ‘Commit Suicide’ Amid Gaza Backlash, Palestinian State Push, Says Israeli FM
Israel’s National Soccer Coach Attacked in Athens Before Soccer Fans Chant ‘F–K Israel, Free Palestine’ at Match
New York Judge Sentences Neo-Nazi to 5 Years for Livestreaming Bomb Threats Against Jewish Hospitals
US Pressures Lebanon to Issue Cabinet Decision to Disarm Hezbollah Before Talks Continue
UK Plans to Recognize Palestinian State in September Unless Israel Meets Conditions, Starmer Says
Israeli Study: Second Vaccine Booster Significantly Lowers COVID Death Rate
Error: Contact form not found.
by Reuters and Algemeiner Staff
A teenager receives a dose of a vaccine against COVID-19 as Israel urged more 12- to 15-year-olds to be vaccinated, citing new outbreaks attributed to the more infectious Delta variant, at a Clalit healthcare maintenance organisation in Tel Aviv, Israel June 21, 2021. Photo: Reuters/Amir Cohen
Senior citizens who received a second booster of the Pfizer-BioNTech COVID-19 vaccination had a 78% lower mortality rate from the disease than those who got one only, a study from Israel showed on Sunday.
The country’s largest healthcare provider, Clalit Health Services, said the 40-day study included more than half a million people aged 60 to 100.
Some 58% of participants had received a second booster — or two shots in addition to the basic two-shot regimen. The remainder had received only one booster. Researchers recorded 92 deaths among the first group and 232 deaths among the second, smaller group.
“The main conclusion is that the second booster is lifesaving,” said Ronen Arbel, Health Outcomes Researcher at Clalit and Sapir College.
The report was issued as a preprint and has not been peer-reviewed. The research excluded people who received rival Moderna’s vaccine and those who had taken oral anti-COVID therapy.
Israeli health officials have put out a number of studies on vaccine efficacy throughout the pandemic that have impacted policymaking in other countries.
